GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

NCT07087002 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Medulloblastoma
Central Nervous System Embryonal Tumor
Refractory Medulloblastoma
Recurrent Medulloblastoma
Pediatric Brain Tumor
Embryonal Tumor With Multilayered Rosettes (ETMR)
Pineoblastoma
Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS
CNS Neuroblastoma
FOXR2-activated

Interventions

BIOLOGICAL: GPC2-CAR T cells
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Stanford University